| Design of glycosylation sites by rapid synthesis and analysis of glycosyltransferases W Kightlinger, L Lin, M Rosztoczy, W Li, MP DeLisa, M Mrksich, ... Nature chemical biology 14 (6), 627-635, 2018 | 141 | 2018 |
| Chemical strategies to boost cancer vaccines WH Li, YM Li Chemical reviews 120 (20), 11420-11478, 2020 | 113 | 2020 |
| Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy JJ Wu, L Zhao, HG Hu, WH Li, YM Li Medicinal research reviews 40 (3), 1117-1141, 2020 | 110 | 2020 |
| Black phosphorous nanosheet: a novel immune-potentiating nanoadjuvant for near-infrared-improved immunotherapy WH Li, JJ Wu, L Wu, BD Zhang, HG Hu, L Zhao, ZB Li, XF Yu, YM Li Biomaterials 273, 120788, 2021 | 49 | 2021 |
| A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant JJ Wu, L Zhao, BB Han, HG Hu, BD Zhang, WH Li, YX Chen, YM Li Chemical Communications 57 (4), 504-507, 2021 | 47 | 2021 |
| Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines JJ Wu, WH Li, PG Chen, BD Zhang, HG Hu, QQ Li, L Zhao, YX Chen, ... Chemical communications 54 (69), 9655-9658, 2018 | 41 | 2018 |
| A chitosan-mediated inhalable nanovaccine against SARS-CoV-2 SH Zhuo, JJ Wu, L Zhao, WH Li, YF Zhao, YM Li Nano Research 15 (5), 4191-4200, 2022 | 35 | 2022 |
| Fully synthetic invariant NKT cell-dependent self-adjuvanting antitumor vaccines eliciting potent immune response in mice PG Chen, HG Hu, ZY Sun, QQ Li, BD Zhang, JJ Wu, WH Li, YF Zhao, ... Molecular Pharmaceutics 17 (2), 417-425, 2019 | 35 | 2019 |
| CASTING: a potent Supramolecular strategy to cytosolically deliver STING agonist for cancer immunotherapy and SARS-CoV-2 vaccination JJ Wu, FY Chen, BB Han, HQ Zhang, L Zhao, ZR Zhang, JJ Li, BD Zhang, ... Ccs Chemistry 5 (4), 885-901, 2023 | 24 | 2023 |
| New opportunities for immunomodulation of the tumour microenvironment using chemical tools JY Su, WH Li, YM Li Chemical Society Reviews 51 (18), 7944-7970, 2022 | 20 | 2022 |
| Rational design of T-cell-and B-cell-based therapeutic cancer vaccines WH Li, JY Su, YM Li Accounts of Chemical Research 55 (18), 2660-2671, 2022 | 19 | 2022 |
| STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation BD Zhang, JJ Wu, WH Li, HG Hu, L Zhao, PY He, YF Zhao, YM Li Nano Research 15 (7), 6328-6339, 2022 | 17 | 2022 |
| Pam3CSK4-CDGSF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING HG Hu, JJ Wu, BD Zhang, WH Li, YM Li Bioconjugate Chemistry 31 (11), 2499-2503, 2020 | 17 | 2020 |
| Regulation of immune activation by optical control of TLR1/2 heterodimerization HG Hu, PG Chen, G Wang, JJ Wu, BD Zhang, WH Li, RL Davis, YM Li ChemBioChem 21 (8), 1150-1154, 2020 | 11 | 2020 |
| Rational design of a cocktail of inhibitors against Aβ aggregation G Li, WY Yang, WH Li, YY Luo, YJ Lim, Y Li, A Paul, D Segal, L Hong, ... Chemistry–A European Journal 26 (16), 3499-3503, 2020 | 11 | 2020 |
